Company: CPMV
Filing Date: 2025-08-19
Form Type: 10-Q
Source: 0001683168-25-006318
Chunk: 2

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-08-19
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
39,141)

    Loss before provision for income taxes 
     (169,628) 
     (293,717) 
     (350,948) 
     (582,209)

    Provision for income taxes 
     2,400  
     –  
     2,400  
     – 

    Net loss 
    $(172,028) 
    $(293,717) 
    $(353,348) 
    $(582,209)

    Basic and diluted loss per common share 
    $(0.02) 
    $(0.04) 
    $(0.05) 
    $(0.08)

    Weighted average number of common shares outstanding – basic and diluted 
     7,236,447  
     7,236,447  
     7,236,447  
     7,236,447 

See accompanying notes to unaudited condensed
consolidated financial statements.

 5 

Mosaic ImmunoEngineering, Inc.

Condensed Consolidated Statements of Stockholders’
Deficit

(Unaudited)

For the Three Months Ended June 30, 2025

    Series A
    Convertible Voting Preferred Stock  
    Series
    B Convertible Voting Preferred Stock  
    Common
    Stock  
    Additional
    Paid-in  
    Accumulated  
    Total
    Stockholders' 

    Shares 
    Amount  
    Shares 
    Amount  
    Shares 
    Amount  
    Capital  
    Deficit  
    Deficit 
  
    Balances, March 31, 2025 
    – 
    $–  
    70,000 
    $1  
    7,242,137 
    $72  
    $2,050,073  
    $(9,019,640) 
    $(6,969,494)

    Net loss 
    – 
     –  
    – 
     –  
    – 
     –  
     –  
     (172,028) 
     (172,028)

    Balances, June 30, 2025 
    – 
    $–  
    70,000 
    $1  
    7,242,137 
    $72  
    $2,050,073  
    $(9,191,